Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Performance of adhesive bone cement containing hydroxyapatite particles

S Morita1, K Furuya, K Ishihara

  • 1Department of Orthopedic Surgery, Faculty of Medicine, Tokyo Medical and Dental University, Japan.

Biomaterials
|November 27, 1998
PubMed
Summary

This study tested a new type of bone cement that includes hydroxyapatite (HA) particles and an adhesion promoter called 4-META. The cement is designed to stick well to both bone and prostheses. Researchers found that adding HA particles to the cement did not reduce its adhesion properties when 4-META was included. In contrast, cements without 4-META showed a significant drop in mechanical strength when HA particles were added. Animal tests showed that the new cement allowed new bone to grow directly onto its surface, suggesting good biocompatibility. These findings indicate that the 4-META cement could be a promising material for orthopedic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cumulative incidence of vancomycin-resistant Enterococcus faecium detection by patient characteristics or possible exposures: prioritization of patients for active screening culture.

The Journal of hospital infection·2024
Same author

Interobserver Reliability on Intravoxel Incoherent Motion Imaging in Patients with Acute Ischemic Stroke.

AJNR. American journal of neuroradiology·2022
Same author

Anisakiasis: The risks of seafood consumption.

Nigerian journal of clinical practice·2018
Same author

Paradoxical localized exacerbation of psoriatic eruptions triggered by secukinumab.

Clinical and experimental dermatology·2018
Same author

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

British journal of cancer·2016
Same author

Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.

European journal of gynaecological oncology·2016

Area of Science:

  • Orthopedic biomaterials development
  • Biocompatible polymer composites
  • Medical adhesion technology

Background:

Current acrylic bone cements face limitations in adhesion to bone and implants. While hydroxyapatite (HA) is known to improve biocompatibility, its inclusion often compromises mechanical strength. Prior research has shown that MMA-based cements struggle with maintaining structural integrity when combined with inorganic fillers. This gap motivated the exploration of adhesion promoters like 4-META. It was already known that 4-META enhances bonding in dental applications. However, its use in orthopedic cements remained untested. No prior work had resolved how HA particles affect adhesion and mechanical properties in MMA-based systems. This study aimed to address the challenge of maintaining both adhesion and mechanical strength in bone cement formulations.

Purpose Of The Study:

The study aimed to evaluate a novel MMA-based bone cement containing 4-META as an adhesion promoter and HA particles as a filler. The specific problem addressed was the trade-off between mechanical strength and adhesion when HA is added. The motivation stemmed from the need for a cement that adheres well to both bone and prostheses. Researchers proposed that 4-META could mitigate the mechanical degradation caused by HA inclusion. The study sought to determine whether 4-META could preserve mechanical strength while maintaining adhesion. Animal implantation was used to assess biocompatibility and bone integration. The goal was to develop a cement that supports bone ingrowth without compromising structural properties.

Keywords:
bone cement adhesionhydroxyapatite in orthopedicsbiocompatible cementMMA-based bone cement

Frequently Asked Questions

4-META enhances adhesion by promoting bonding between the cement matrix and HA particles, preserving mechanical strength.

HA particles act as a bone-compatible filler, improving biocompatibility without compromising adhesion properties.

Mechanical strength ensures the cement can support prostheses and withstand physiological loads without degradation.

Animal implantation models were used to assess whether new bone formed direct contact with the cement surface.

No, HA particles did not affect adhesion to metal surfaces in the 4-META cement formulation.

Related Experiment Videos

Main Methods:

The study compared two types of MMA-based bone cement: one with 4-META and another without. HA particles were added to both formulations as a filler. Mechanical strength was measured under varying HA concentrations. Adhesion to bone and metal prostheses was tested using standardized protocols. The 4-META cement was analyzed for its ability to maintain structural integrity with HA inclusion. Animal implantation models were used to assess in vivo adhesion and bone integration. Histological analysis confirmed whether new bone contacted the cement directly. The methods focused on evaluating both mechanical and biological performance of the cement formulations.

Main Results:

The 4-META cement retained mechanical strength even with HA addition, unlike the non-4-META cement, which showed significant strength loss. Adhesion to bone and metal remained unaffected by HA inclusion in the 4-META cement. Mechanical strength degradation was observed in the non-4-META cement as HA percentage increased. The HA particles in the 4-META cement did not compromise adhesion properties. In vivo tests showed that new bone formed direct contact with the 4-META cement. Bone ingrowth was not hindered by the presence of HA particles. The 4-META cement demonstrated biocompatibility and integration with surrounding bone tissue. These findings suggest that 4-META effectively preserves mechanical and adhesive properties in HA-containing cements.

Conclusions:

The authors propose that 4-META enhances adhesion without compromising mechanical strength in MMA-based cements. The HA particles did not negatively impact adhesion to bone or metal surfaces. Mechanical degradation observed in non-4-META cements was avoided in the 4-META formulation. The in vivo results suggest that the 4-META cement supports bone integration. The study supports the use of 4-META as an effective adhesion promoter in orthopedic cements. The findings indicate that HA particles can be safely incorporated without affecting adhesion properties. The cement formulation demonstrated biocompatibility and did not hinder bone ingrowth. These results suggest potential clinical applications for the 4-META cement in orthopedic procedures.

The findings suggest that 4-META cement may be suitable for orthopedic applications requiring strong adhesion and biocompatibility.